the V3 loop is more sensitive than single PCR for detecting CXCR4-using viruses. Patients and methods: The V3 genotypes of the HIV-1 infecting 152 patients enrolled in the multicentre Geno-Tropism ANRS study were determined by all the participating laboratories using a single PCR and V3 bulk sequencing. In parallel, one laboratory determined the V3 genotype using duplicate PCR and bulk sequencing of pooled amplicons. HIV tropism was predicted with the geno2pheno10 algorithm. The phenotypes of all samples were determined with the Trofile assay and the Toulouse tropism test (TTT) recombinant virus assay. Results: Geno2pheno10 was 56.8 % sensitive and 75.9 % specific when compared with the Trofile assay for detect-ing CXCR4-using viruses after...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
PURPOSE: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
International audienceOBJECTIVES: To determine whether genotyping of HIV-1 by duplicate PCR amplific...
The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the ...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
AbstractUse of CCR5 antagonists requires previous viral tropism determination. The available methods...
Objective. The use of CCR5 inhibitors requires a tool to predict human immunodeficiency virus type 2...
The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the ...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
PURPOSE: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...
International audienceOBJECTIVES: To determine whether genotyping of HIV-1 by duplicate PCR amplific...
The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the ...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high ...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co-receptor us...
BACKGROUND: Trofile is the prospectively validated HIV-1 tropism assay. Its use is limited by high c...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
AbstractUse of CCR5 antagonists requires previous viral tropism determination. The available methods...
Objective. The use of CCR5 inhibitors requires a tool to predict human immunodeficiency virus type 2...
The false-positive rate (FPR) is a percentage-score provided by Geno2Pheno-algorithm indicating the ...
<div><p>A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected ...
A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individu...
PURPOSE: We have developed a sequencing assay for determining the usage of the genotypic HIV-1 co...
Key clinical studies for HIV coreceptor antagonists have used the phenotyping-based Trofile test. Me...